| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 08/04/2004 | EP1442058A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 08/04/2004 | EP1442049A2 Substituted amino ketone compounds |
| 08/04/2004 | EP1441750A2 Linear and cyclic melanocortin receptor-specific peptides |
| 08/04/2004 | EP1441720A1 Inhibitors of serine protease, particularly hepatitis c virus ns3-ns4a protease, incorporating a fused ring system |
| 08/04/2004 | EP0764171B1 Ligands for induction of antigen specific apoptosis in t cells |
| 08/04/2004 | CN1518592A Male contraceptives |
| 08/04/2004 | CN1518558A Peptides and/or proteins and use thereof for production of therapeutic and/or prophylactic medicament |
| 08/04/2004 | CN1160368C Endothelin antegon |
| 08/03/2004 | US6770741 Useful in treating conditions and diseases of a mammal and human in which an excess of bradykinin or related kinins are produced or injected such as by insect bites |
| 08/03/2004 | US6770626 Amino acid sequence from certain regions of tissue growth factor-beta super family serine-threonine kinase receptors |
| 08/03/2004 | US6770595 Cyclic imines as pesticides |
| 08/03/2004 | US6770438 Oncogene, oncoprotein; associated with tumorigenicity; mn genes from cellular component of matu, a quasi viral agent derived from a human mammary tumor |
| 08/03/2004 | US6770259 Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation |
| 07/29/2004 | WO2004063963A2 Novel proteins with altered immunogenicity |
| 07/29/2004 | WO2004063217A1 Dimerized peptide |
| 07/29/2004 | WO2004063216A1 Conjugate for retention in blood and cancer tissue-specific drug delivery |
| 07/29/2004 | WO2004063213A2 Peptides which target tumor and endothelial cells, compositions and uses thereof |
| 07/29/2004 | WO2004063212A2 Organic compounds with biological action as thrombin inhibitors and use therof |
| 07/29/2004 | WO2004062574A2 Improved linkers for radiopharmaceutical compounds |
| 07/29/2004 | WO2004062556A2 Methods for preventing and treating alzheimer’s disease (ad) |
| 07/29/2004 | WO2004062475A2 Fluorescent assays for protein kinases |
| 07/29/2004 | WO2004052404A3 Glycogen synthase kinase-3 inhibitors |
| 07/29/2004 | WO2004043993A3 Novel ampiphilic fluorocarbon molecular vectors for biomedical and medical use |
| 07/29/2004 | WO2004041297A3 Modified cytokines for use in cancer therapy |
| 07/29/2004 | WO2004035613A3 4-methylhexanoic kahalaide f compound |
| 07/29/2004 | WO2004015392A3 Improved method to identify targeting molecules |
| 07/29/2004 | WO2003099853A3 Petide amidation process |
| 07/29/2004 | WO2003033644A3 Peptide useful in immunomodulation |
| 07/29/2004 | US20040147716 Peptides comprising aromatic D-amino acids and methods of use |
| 07/29/2004 | US20040147483 For therapy of viral infection |
| 07/29/2004 | US20040147450 To promote bone growth in mammals |
| 07/29/2004 | US20040147432 Melanin-concentrating hormone analogs |
| 07/29/2004 | US20040146964 Assays, methods and means |
| 07/29/2004 | US20040146959 for detecting the phosphorylation activity of one or more protein kinases in a sample; fluorescent dye linked phosphorylable substrate |
| 07/29/2004 | US20040146930 for diagnosing susceptibility to a pathological condition based on the presence or absence of mutation; drug screening; genetic engineering |
| 07/29/2004 | US20040146549 Amino acid sequences capable of facilitating penetration across a biological barrier |
| 07/29/2004 | US20040146525 Shellfish protein |
| 07/29/2004 | US20040146522 For therapy of individual exposed to or infected with HIV-1 |
| 07/29/2004 | DE10301255A1 Organische Verbindungen mit biologischer Wirkung als Thrombinhemmer und ihre Verwendung Organic compounds having biological activity as thrombin inhibitors and their use |
| 07/29/2004 | CA2551593A1 Affinity screening using "one-bead-one-compound" libraries |
| 07/29/2004 | CA2513701A1 Dimerized peptide |
| 07/29/2004 | CA2513466A1 Organic compounds with biological action as thrombin inhibitors and use thereof |
| 07/29/2004 | CA2513218A1 Peptides and uses thereof for preventing and treating alzheimer's disease(ad) |
| 07/29/2004 | CA2512693A1 Novel proteins with altered immunogenicity |
| 07/29/2004 | CA2506813A1 Peptides which target tumor and endothelial cells, compositions and uses thereof |
| 07/28/2004 | EP1439852A1 Peptides and related compounds having thrombopoietic activity |
| 07/28/2004 | EP1439849A2 Use of calmodulin kinase ii inhibitors to treat myocardial dysfunction in structural heart disease |
| 07/28/2004 | EP1401473A4 Transporters comprising spaced arginine moieties |
| 07/28/2004 | CN1516598A Antimicrobial peptides |
| 07/28/2004 | CN1159584C Method and medicine box of testing anti-hepatitis C virus antibody |
| 07/28/2004 | CN1159338C LHRH tandem repeat peptide and vaccine and immunogenic composition |
| 07/27/2004 | US6767995 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/27/2004 | US6767993 Methods and compositions for peptide synthesis |
| 07/27/2004 | US6767991 Peptides and analogs thereof; viral protease inhibitors, pharmaceutical compositions containing such peptides and ribavirin |
| 07/27/2004 | US6767897 Therapeutic uses of tri-, tetra-, penta-, and polypeptides |
| 07/27/2004 | US6767890 Administering leu-pro-pro-ser-arg pentapeptide |
| 07/22/2004 | WO2004060389A1 1-desamino-8-d-arginyl vasopressin analogs |
| 07/22/2004 | WO2004060385A1 Ophthalmic therapeutic composition |
| 07/22/2004 | WO2004060302A2 Methods and compositions for the diagnosis, prognosis, and treatment of cancer |
| 07/22/2004 | WO2004021977A3 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |
| 07/22/2004 | WO2004007661A3 Carboxy protection strategies for acidic c-terminal amino acids in chemical ligation of oligopeptides |
| 07/22/2004 | WO2004005529A3 GEF-H1b: BIOMARKERS, COMPLEXES, ASSAYS AND THERAPEUTIC USES THEREOF |
| 07/22/2004 | US20040142876 peptidic phenethylamides; non-covalent inhibitors of serine protease |
| 07/22/2004 | US20040142874 peptides which modulate anaphylactic, endotoxic and inflammatory reactions in mammals; obtained from mammalian submandibular glands |
| 07/22/2004 | US20040142385 Cell wall mannoproteins and active epitopes from candida albicans and antibodies recognizing them |
| 07/22/2004 | CA2511816A1 Methods and compositions for the diagnosis, prognosis, and treatment of cancer |
| 07/21/2004 | EP1438966A2 Use of depsipeptide and congeners thereof as immunosuppressants for treating an infectious disease, an autoimmune disease, allergic reactions or a hyperproliferative skin disease |
| 07/21/2004 | EP1438586A1 Fret protease assays for clostridial toxins |
| 07/21/2004 | EP1438333A2 Anti-fusion assay |
| 07/21/2004 | EP1438330A2 Peptide decoys for the preparation of medicaments that are intended for the prevention or treatment of autoimmune pathologies or problems linked to the appearance of antibodies directed against exogenous proteins |
| 07/21/2004 | EP1438329A1 Biologically active peptides and their use for repairing injured nerves |
| 07/21/2004 | EP1289571B1 Prochelators of radiometal labeled molecules |
| 07/21/2004 | EP1040121B1 Novel method for preparing cylosporin derivatives |
| 07/21/2004 | CN1514878A Method for detecting calpain 3 activity in biological sample and peptides for implementsing said method |
| 07/21/2004 | CN1514844A Modified granulocyte colony stimulating factor (G-CSF) with reduced immunogenicity |
| 07/21/2004 | CN1514843A Somatostatin-dopamine chimeric analogs |
| 07/21/2004 | CN1514733A Modified erythropoietin (EPO) with reduced immunogenicity |
| 07/21/2004 | CN1513997A Method of detecting 5'-methioadenosine phosphorylase defect type mammarian cell |
| 07/21/2004 | CN1513872A Liquid phase sgnthesis method of thymus pentapeptide |
| 07/20/2004 | US6765099 Neo-tryptophan |
| 07/20/2004 | US6764768 Controlled release composition |
| 07/20/2004 | CA2246456C Lipids and their use, for example, in liposomes |
| 07/20/2004 | CA2103148C Determination of motifs of peptides on mhc molecules |
| 07/20/2004 | CA2096159C Peptides that induce antibodies which neutralize genetically divergent hiv-1 isolates |
| 07/15/2004 | WO2004058988A2 Binding agents which inhibit myostatin |
| 07/15/2004 | WO2004058804A1 Peptides and therapeutic uses thereof |
| 07/15/2004 | WO2004058803A2 Peptides that bind of the vegfr-2 |
| 07/15/2004 | WO2004058802A1 Peptides that bind to the heparin binding domian of vegf and vegfr-2 |
| 07/15/2004 | WO2004058799A2 Methods and compositions for inhibiting binding of ige to a high affinity receptor |
| 07/15/2004 | WO2004042350A3 Using amines or amino acids as mobile phase modifiers in chromatography |
| 07/15/2004 | WO2004030650A3 Administration form for pharmaceutically active peptides with sustained release and method for the production thereof |
| 07/15/2004 | WO2003100033A3 ANTI-αvβ6 ANTIBODIES |
| 07/15/2004 | WO2003082197A3 Immunosuppressant compounds, methods and uses related thereto |
| 07/15/2004 | WO2003065974A3 Hexa-, hepta-, and octapeptides having antiangiogenic activity |
| 07/15/2004 | WO2003047506A3 Peptide agonists of prostate-specific antigen, and uses therefor |
| 07/15/2004 | US20040138411 lyophilization of an aqueous mixture comprising a boronic add compound and a compound having at least two hydroxyl groups produces a stable composition that readily releases the boronic acid compound upon dissolution in aqueous media |
| 07/15/2004 | US20040138137 Alloferons - immunomodulatory peptides |
| 07/15/2004 | US20040138136 Cyclic peptide compositions and methods for treatment of sexual dysfunction |
| 07/15/2004 | US20040138135 immunogens; immunotherapy; antigen presenting cells |
| 07/15/2004 | US20040138133 tat genes/proteins; transport proteins; kits; for treating neovascular glaucoma, diabetic retinopathy, retrolental fibroplasia, hemangiomas, angiofibromas, psoriasis, osteoarthritis, rheumatoid arthritis, and cancers |